Attachment No. 3 - Questions Answers.pdf

PDF 79 KB Posted

Attached to
Sequencing Service to Support Gene Therapy Research Federal contract opportunity
Solicitation number
FDA-RFQ-1255498
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

View the file

Other files for this federal contract opportunity

Other files attached to Sequencing Service to Support Gene Therapy Research, newest first.
File Type Posted
Sol_Doc_Amend No.1.pdf PDF
Sol_Doc .pdf PDF
Attachment No. 1 - FAR Class Deviation 2020-05.pdf PDF
Attachment No. 2 - HHS Class Deviation 2020-20.docx DOCX document

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Attachment No: 3 – Question & Answers

FDA-RFQ-1255498 – Amendment # 1

Sequencing Service to Support Gene Therapy Research

Questions & Answers

Q1. Were the DNA samples purified in a CLIA-certified laboratory?

A1. No

Q2. Do the DNA specimens have a standard concentration or a range of expected concentrations?

A2. 50 – 200 ng/uL

Q3 Do the DNA specimens have a standard volume or a range of expected volumes?

A3. 5-20 uL

Q4. What is the expected purity of the DNA specimen or range of purity measured by

260/280 ratios?

A4. 1.8-2.0

Q5. Will the DNA specimens be frozen or have been frozen at any point in their lifecycle?

A5. Yes

End of Question & Answers.

File details come from the government source that posted it. Updated .